Heat-shock protein complexes serve as cancer drug targets | Chemical & Engineering News
Volume 94 Issue 40 | pp. 10-11 | Concentrates
Issue Date: October 10, 2016

Heat-shock protein complexes serve as cancer drug targets

‘Epichaperomes’ that form in some cancer cells might enable selective therapies
Department: Science & Technology
News Channels: Biological SCENE
Keywords: cancer, epichaperome, chaperone, heat-shock protein

Researchers have discovered that heat-shock proteins, which help cells respond to stresses such as nutrient and oxygen shortages, form large “epichaperome” protein complexes in some cancer cells. Monica L. Guzman of Weill Cornell Medical College, Gabriela Chiosis of Memorial Sloan Kettering Cancer Center, and coworkers, who carried out the study, propose that the known drug sensitivity of one of the proteins and the prevalence of epichaperomes in cancer cells may make the complexes selective targets . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society